Compare GPRE & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPRE | STAA |
|---|---|---|
| Founded | 2004 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 812.2M | 867.9M |
| IPO Year | 2004 | 1995 |
| Metric | GPRE | STAA |
|---|---|---|
| Price | $15.23 | $17.45 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 9 |
| Target Price | $11.19 | ★ $22.19 |
| AVG Volume (30 Days) | ★ 1.2M | 1.2M |
| Earning Date | 05-07-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,091,680,000.00 | $239,442,000.00 |
| Revenue This Year | N/A | $33.83 |
| Revenue Next Year | $11.85 | $8.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.14 | $14.69 |
| 52 Week High | $16.80 | $30.81 |
| Indicator | GPRE | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 42.41 |
| Support Level | $9.25 | $17.13 |
| Resistance Level | $15.64 | $18.19 |
| Average True Range (ATR) | 0.90 | 0.92 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 54.44 | 14.29 |
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.